Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Vaccines: from empirical development to rational design.

Rueckert C, Guzmán CA.

PLoS Pathog. 2012;8(11):e1003001. doi: 10.1371/journal.ppat.1003001. Epub 2012 Nov 8. Review.

2.

Vaccine adjuvants: key tools for innovative vaccine design.

Riese P, Schulze K, Ebensen T, Prochnow B, Guzmán CA.

Curr Top Med Chem. 2013;13(20):2562-80. Review.

PMID:
24066891
3.

Molecular signatures of vaccine adjuvants.

Olafsdottir T, Lindqvist M, Harandi AM.

Vaccine. 2015 Sep 29;33(40):5302-7. doi: 10.1016/j.vaccine.2015.04.099. Epub 2015 May 16. Review.

4.

Nasal and pulmonary vaccine delivery using particulate carriers.

Jia Y, Krishnan L, Omri A.

Expert Opin Drug Deliv. 2015 Jun;12(6):993-1008. doi: 10.1517/17425247.2015.1044435. Epub 2015 May 8. Review.

PMID:
25952104
5.

Intranasal formulations: promising strategy to deliver vaccines.

Riese P, Sakthivel P, Trittel S, Guzmán CA.

Expert Opin Drug Deliv. 2014 Oct;11(10):1619-34. doi: 10.1517/17425247.2014.931936. Epub 2014 Jun 25. Review.

PMID:
24962722
6.

New developments in vaccine research--unveiling the secret of vaccine adjuvants.

de Veer M, Meeusen E.

Discov Med. 2011 Sep;12(64):195-204. Review.

7.

Vaccination for contraception.

Jones WR.

Aust N Z J Obstet Gynaecol. 1994 Jun;34(3):320-9. Review.

PMID:
7848209
8.

A rational, systematic approach for the development of vaccine formulations.

Morefield GL.

AAPS J. 2011 Jun;13(2):191-200. doi: 10.1208/s12248-011-9261-1. Epub 2011 Feb 23. Review.

9.

Molecular basis of vaccination.

Del Giudice G, Pizza M, Rappuoli R.

Mol Aspects Med. 1998 Feb;19(1):1-70. Review.

PMID:
9789264
10.

Mucosal delivery of vaccine antigens and its advantages in pediatrics.

De Magistris MT.

Adv Drug Deliv Rev. 2006 Apr 20;58(1):52-67. Epub 2006 Mar 3. Review.

PMID:
16516335
11.

Immune modulators with defined molecular targets: cornerstone to optimize rational vaccine design.

Ebensen T, Guzmán CA.

Hum Vaccin. 2008 Jan-Feb;4(1):13-22. Epub 2008 Jan 10. Review.

PMID:
18376145
12.

Novel vaccine development strategies for inducing mucosal immunity.

Fujkuyama Y, Tokuhara D, Kataoka K, Gilbert RS, McGhee JR, Yuki Y, Kiyono H, Fujihashi K.

Expert Rev Vaccines. 2012 Mar;11(3):367-79. doi: 10.1586/erv.11.196. Review.

13.

Delivery technologies for human vaccines.

Moingeon P, de Taisne C, Almond J.

Br Med Bull. 2002;62:29-44. Review.

PMID:
12176848
14.

Proteomics approaches towards antigen discovery and vaccine development.

Klade CS.

Curr Opin Mol Ther. 2002 Jun;4(3):216-23. Review.

PMID:
12139306
15.

Salmonella enterica as a vaccine carrier.

Hegazy WA, Hensel M.

Future Microbiol. 2012 Jan;7(1):111-27. doi: 10.2217/fmb.11.144. Review.

PMID:
22191450
16.

Systems vaccinology: Enabling rational vaccine design with systems biological approaches.

Hagan T, Nakaya HI, Subramaniam S, Pulendran B.

Vaccine. 2015 Sep 29;33(40):5294-301. doi: 10.1016/j.vaccine.2015.03.072. Epub 2015 Apr 6. Review.

17.

From vaccine practice to vaccine science: the contribution of human immunology to the prevention of infectious disease.

Mortellaro A, Ricciardi-Castagnoli P.

Immunol Cell Biol. 2011 Mar;89(3):332-9. doi: 10.1038/icb.2010.152. Epub 2011 Feb 8. Review.

PMID:
21301476
18.

Novel adjuvants and delivery systems for enhancing immune responses induced by immunogens.

Dey AK, Srivastava IK.

Expert Rev Vaccines. 2011 Feb;10(2):227-51. doi: 10.1586/erv.10.142. Review.

PMID:
21105782
19.

Improving vaccine performance with adjuvants.

Vogel FR.

Clin Infect Dis. 2000 Jun;30 Suppl 3:S266-70. Review.

PMID:
10875797
20.

Adjuvants for veterinary vaccines--types and modes of action.

Gerdts V.

Berl Munch Tierarztl Wochenschr. 2015 Nov-Dec;128(11-12):456-63. Review.

PMID:
26697712

Supplemental Content

Support Center